[New year, new resolutions? 2019: Some changes in continuity]

Bull Cancer. 2019 Jan;106(1):2-3. doi: 10.1016/j.bulcan.2019.01.001.

[Article in French]

Authors

Jacques-Olivier Bay¹, Gilles L'Allemain²; comité de rédaction du Bulletin du cancer

Affiliations

¹ CHU de Clermont-Ferrand, service de thérapie cellulaire et d'hématologie clinique adulte, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France. Electronic address: jobay@chu-clermontferrand.fr.
² Université de Nice Sophia-Antipolis, CNRS-Inserm-UNS, institut de biologie Valrose, 06108 Nice cedex 2, France.

PMID: 30709565
DOI: 10.1016/j.bulcan.2019.01.001

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Cell Line, Tumor / drug effects
Complementary Therapies
Food, Organic
Gastrointestinal Microbiome
Humans
Immunotherapy
Neoplasms* / therapy
Periodicals as Topic*